Business
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2016 Conference Call
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2016 Conference Call Canada ...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nNotice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2016 Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMISSISSAUGA, ON, Feb. 16, 2017\n\n\n\nMISSISSAUGA, ON, Feb. 16, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it will host a conference call its Q4 and full-year 2016 financial results on Thursday, March 2, 2017. \n\nQ4 AND YEAR-END 2016 CONFERENCE CALL\n\nWHEN: Thursday, March 2, 2017 at 8:30AM ET\n\nCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2kOtP5S. An archived replay of the webcast will be available for 90 days.\n\nAbout Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX:CPH) is a growing specialty pharmaceutical dermatology company, with a robust and diversified portfolio of commercial and early to late-stage products. Through multiple transactions, Cipher has built its U.S. commercial presence, expanded its Canadian dermatology franchise and broadened its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\nTo view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/February2017/16/c3031.html\n\n\n\n\nInvestors: In Canada: Craig Armitage, LodeRock Advisors, (416) 347-8954, [email protected]; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, [email protected] CNW Group 2017","length":2913,"tagName":"div"}]